These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19386577)

  • 1. Intrinsic motivation inventory: an adapted measure for schizophrenia research.
    Choi J; Mogami T; Medalia A
    Schizophr Bull; 2010 Sep; 36(5):966-76. PubMed ID: 19386577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia.
    Nakagami E; Hoe M; Brekke JS
    Schizophr Bull; 2010 Sep; 36(5):935-48. PubMed ID: 20462998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: testing mediator and moderator effects.
    Nakagami E; Xie B; Hoe M; Brekke JS
    Schizophr Res; 2008 Oct; 105(1-3):95-104. PubMed ID: 18715756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic motivation in schizophrenia: relationships to cognitive function, depression, anxiety, and personality.
    Barch DM; Yodkovik N; Sypher-Locke H; Hanewinkel M
    J Abnorm Psychol; 2008 Nov; 117(4):776-787. PubMed ID: 19025225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic motivation and learning in a schizophrenia spectrum sample.
    Choi J; Medalia A
    Schizophr Res; 2010 May; 118(1-3):12-9. PubMed ID: 19716270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia.
    Bryce SD; Lee SJ; Ponsford JL; Lawrence RJ; Tan EJ; Rossell SL
    Schizophr Res; 2018 Dec; 202():354-360. PubMed ID: 29935884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expectancy-value theory in persistence of learning effects in schizophrenia: role of task value and perceived competency.
    Choi J; Fiszdon JM; Medalia A
    Schizophr Bull; 2010 Sep; 36(5):957-65. PubMed ID: 20634277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric properties of performance-based measurements of functional capacity: test-retest reliability, practice effects, and potential sensitivity to change.
    Leifker FR; Patterson TL; Bowie CR; Mausbach BT; Harvey PD
    Schizophr Res; 2010 Jun; 119(1-3):246-52. PubMed ID: 20399613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of trait to state motivation: the role of self-competency beliefs.
    Choi KH; Saperstein AM; Medalia A
    Schizophr Res; 2012 Aug; 139(1-3):73-7. PubMed ID: 22627122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the MUSIC Model of Motivation Inventory for use with cognitive training for schizophrenia spectrum disorders: A multinational study.
    Hansen MC; Jones BD; Eack SM; Glenthøj LB; Ikezawa S; Iwane T; Kidd SA; Lepage M; Lindenmayer JP; Ljuri I; Maida K; Matsuda Y; Nakagome K; Nordentoft M; Ozog V; Penney D; Saperstein AM; Sunaga A; Vinogradov S; Virdee G; Wojtalik JA; Medalia A
    Schizophr Res; 2019 Apr; 206():142-148. PubMed ID: 30580895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia.
    Pino O; Guilera G; Rojo JE; Gómez-Benito J; Bernardo M; Crespo-Facorro B; Cuesta MJ; Franco M; Martinez-Aran A; Segarra N; Tabarés-Seisdedos R; Vieta E; Purdon SE; Díez T; Rejas J;
    Schizophr Res; 2008 Feb; 99(1-3):139-48. PubMed ID: 17959358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].
    Zanello A; Weber Rouget B; Gex-Fabry M; Maercker A; Guimon J
    Encephale; 2006; 32(1 Pt 1):45-59. PubMed ID: 16633290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring motivation in schizophrenia: is a general state of motivation necessary for task-specific motivation?
    Choi J; Choi KH; Felice Reddy L; Fiszdon JM
    Schizophr Res; 2014 Mar; 153(1-3):209-13. PubMed ID: 24529609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia.
    Brekke JS; Hoe M; Long J; Green MF
    Schizophr Bull; 2007 Sep; 33(5):1247-56. PubMed ID: 17255120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do people with schizophrenia who have objective cognitive impairment identify cognitive deficits on a self report measure?
    Medalia A; Thysen J; Freilich B
    Schizophr Res; 2008 Oct; 105(1-3):156-64. PubMed ID: 18718740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.
    Engel M; Lincoln TM
    Compr Psychiatry; 2016 Feb; 65():110-5. PubMed ID: 26773998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.
    Strauss GP; Keller WR; Buchanan RW; Gold JM; Fischer BA; McMahon RP; Catalano LT; Culbreth AJ; Carpenter WT; Kirkpatrick B
    Schizophr Res; 2012 Dec; 142(1-3):88-92. PubMed ID: 23127378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an instrument for assessing self-efficacy in schizophrenic spectrum disorders.
    McDermott BE
    J Clin Psychol; 1995 May; 51(3):320-31. PubMed ID: 7560131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.
    Kring AM; Gur RE; Blanchard JJ; Horan WP; Reise SP
    Am J Psychiatry; 2013 Feb; 170(2):165-72. PubMed ID: 23377637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.